Request that the FDA declare that the proposed drug product, Meropenem for Injection and Sodium Chloride Injection, 2 g in Dual-Mix® Container is suitable for submission as an ANDA.
🏛 Food and Drug Administration (FDA)FDA-2026-P-8515
Documents
5
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Jul 31, 2026No comment period
- Other· Jul 31, 2026No comment period